PHARM News

Pharming Group to report first quarter 2026 financial results and provide business update on May 7

Pharming Group announces the 2026 Annual General Meeting of Shareholders

Pharming Group to participate in April investor conferences

Pharming Group announces the filing of its 2025 Annual Report and Form 20-F

Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older

Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older

Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow

Pharming Group to report fourth quarter and full year 2025 financial results and provide business update on March 12

Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day